CRIS Current Research Information System

Gatti, M., Pea, F. (2026). Re: ‘Pharmacokinetics, target attainment and outcomes of piperacillin/tazobactam in critically ill patients receiving continuous infusion with therapeutic drug monitoring: a retrospective analysis’ by Chiriac et al. CLINICAL MICROBIOLOGY AND INFECTION, 10.1016/j.cmi.2026.05.006, 1-2 [10.1016/j.cmi.2026.05.006].

Re: ‘Pharmacokinetics, target attainment and outcomes of piperacillin/tazobactam in critically ill patients receiving continuous infusion with therapeutic drug monitoring: a retrospective analysis’ by Chiriac et al

Gatti, Milo;Pea, Federico
2026
2026
Gatti, M., Pea, F. (2026). Re: ‘Pharmacokinetics, target attainment and outcomes of piperacillin/tazobactam in critically ill patients receiving continuous infusion with therapeutic drug monitoring: a retrospective analysis’ by Chiriac et al. CLINICAL MICROBIOLOGY AND INFECTION, 10.1016/j.cmi.2026.05.006, 1-2 [10.1016/j.cmi.2026.05.006].
Gatti, Milo; Pea, Federico
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/1064171
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex ND
social impact